Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Artificial Intelligence in Medicine
|
August 11, 2000
Toward interactive scheduling systems for managing medical resources
A Oddi, A Cesta
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy
F Recchia, A Cesta, S Rea
Plant Physiology
|
September 1, 1985
Determination of diamine oxidase in lentil seedlings by enzymic activity and immunoreactivity
R Federico, R Angelini, A Cesta, et al.
Journal of Palliative Medicine
|
July 10, 2009
Life-supportive therapy withdrawal and length of stay in a large oncologic intensive care unit at the end of life
Mark A Cesta, Marylou Cardenas-Turanzas, Chris Wakefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer
F Recchia, S De Filippis, M Rosselli, et al.
British Journal of Cancer
|
October 7, 2004
Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX
F Recchia, G Saggio, A Nuzzo, et al.
Journal of Critical Care
|
July 7, 2009
Factors associated with anemia in patients with cancer admitted to an intensive care unit
Marylou Cardenas-Turanzas, Mark A Cesta, Chris Wakefield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2005
High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer
R Mattioli, C Massacesi, F Recchia, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 8, 2008
Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3
C I Tang, D A Loblaw, P Cheung, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Artificial Intelligence in Medicine
|
August 11, 2000
Toward interactive scheduling systems for managing medical resources
A Oddi, A Cesta
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy
F Recchia, A Cesta, S Rea
Plant Physiology
|
September 1, 1985
Determination of diamine oxidase in lentil seedlings by enzymic activity and immunoreactivity
R Federico, R Angelini, A Cesta, et al.
Journal of Palliative Medicine
|
July 10, 2009
Life-supportive therapy withdrawal and length of stay in a large oncologic intensive care unit at the end of life
Mark A Cesta, Marylou Cardenas-Turanzas, Chris Wakefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer
F Recchia, S De Filippis, M Rosselli, et al.
British Journal of Cancer
|
October 7, 2004
Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX
F Recchia, G Saggio, A Nuzzo, et al.
Journal of Critical Care
|
July 7, 2009
Factors associated with anemia in patients with cancer admitted to an intensive care unit
Marylou Cardenas-Turanzas, Mark A Cesta, Chris Wakefield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2005
High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer
R Mattioli, C Massacesi, F Recchia, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 8, 2008
Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3
C I Tang, D A Loblaw, P Cheung, et al.
Page
of 1